As of Jul 02
| +0.0031 / +1.58%|
The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 1.45, with a high estimate of 1.45 and a low estimate of 1.45. The median estimate represents a +628.64% increase from the last price of 0.20.
The current consensus among 1 polled investment analysts is to Buy stock in Hemispherx Biopharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.